Advertisement
Canada markets close in 4 hours 35 minutes

  • S&P/TSX

    21,917.17
    +31.79 (+0.15%)
     

  • S&P 500

    5,096.46
    +48.04 (+0.95%)
     

  • DOW

    38,153.72
    +67.92 (+0.18%)
     

  • CAD/USD

    0.7304
    -0.0019 (-0.26%)
     

  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     

  • Bitcoin CAD

    87,114.55
    +102.81 (+0.12%)
     

  • CMC Crypto 200

    1,383.71
    -12.82 (-0.96%)
     

  • GOLD FUTURES

    2,345.90
    +3.40 (+0.15%)
     

  • RUSSELL 2000

    1,997.71
    +16.59 (+0.84%)
     

  • 10-Yr Bond

    4.6650
    -0.0410 (-0.87%)
     

  • NASDAQ

    15,918.92
    +307.16 (+1.97%)
     

  • VOLATILITY

    15.42
    +0.05 (+0.33%)
     

  • FTSE

    8,142.42
    +63.56 (+0.79%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

URGENT NEWS: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Merger

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Audentes Therapeutics, Inc (BOLD) related to its sale to Astellas Pharma, Inc. Under the terms of the Agreement, Audentes shareholders will have the right to receive $60.00 in cash for each Audentes common stock owned. Click here for more information: https://www.monteverdelaw.com/case/audentes-therapeutics-inc. It is free and there is no cost or obligation to you.

  • Progenics Pharmaceuticals, Inc. (PGNX) related to its sale to Lantheus Holdings, Inc. Under the terms of the transaction, each share of Progenics common stock issued will automatically be converted into the right to receive 0.2502 of a share of Lantheus common stock for each share Progenics common stock. Click here for more information: https://www.monteverdelaw.com/case/progenics-pharmaceuticals-inc. It is free and there is no cost or obligation to you.

  • Central European Media Enterprises Ltd (CETV) related to its sale to TV Bidco B.V. Under the terms of the Agreement, Shareholders of CETV common stock will have the right to receive $4.58 in cash for each CETV common stock owned. Click here for more information: https://www.monteverdelaw.com/case/central-european-media-enterprises-ltd. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

ADVERTISEMENT

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/570226/URGENT-NEWS-Monteverde-Associates-PC-Reminds-Investors-of-its-Ongoing-Investigation-Regarding-the-Merger